相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer
Leonardo Franz et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2021)
Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic
Feng Gao et al.
CURRENT CANCER DRUG TARGETS (2020)
Tumor microenvironment components: Allies of cancer progression
Pablo Igor Ribeiro Franco et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle
Yuan Zhuang et al.
ONCOTARGETS AND THERAPY (2020)
Maspin expression and anti-apoptotic pathway regulation by bcl2 in laryngeal cancer
Andrea Lovato et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis
Leonardo Franz et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Prognostic Significance of CD105-and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma
Gino Marioni et al.
CANCERS (2020)
Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality
Xiaohan Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
CD105-and CD31-assessed microvessel density in laryngeal carcinoma biopsies as a predictor of recurrence after exclusive primary surgery
Leonardo Franz et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
Immunotherapy combinations for the treatment of patients with solid tumors
Maria Virginia Bluthgen et al.
FUTURE ONCOLOGY (2020)
Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma
Lara Alessandrini et al.
ORAL ONCOLOGY (2020)
Postoperative radiotherapy for laryngeal cancer. The prognostic role of programmed death-ligand 1: An immune microenvironment-based cluster analysis
Leonardo Franz et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
Yuxiao Song et al.
FRONTIERS IN IMMUNOLOGY (2020)
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
Ming Yi et al.
MOLECULAR CANCER (2019)
Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors
Ning Zhu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautes-Fridman et al.
NATURE REVIEWS CANCER (2019)
CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma
Anke Schuelter et al.
BMC CANCER (2018)
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer
Giovanna Armani et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Maria Georganaki et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R. Ramjiawan et al.
ANGIOGENESIS (2017)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
The non-canonical role of vascular endothelial growth factor-C axis in cancer progression
Chu-An Wang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Vascular Endothelial Growth Factor C Disrupts the Endothelial Lymphatic Barrier to Promote Colorectal Cancer Invasion
Carlotta Tacconi et al.
GASTROENTEROLOGY (2015)
Targeting angiogenesis in head and neck cancer
Maria Vassilakopoulou et al.
ORAL ONCOLOGY (2015)
Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma
Patcharee Ritprajak et al.
ORAL ONCOLOGY (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
Kurt A. Schalper et al.
CLINICAL CANCER RESEARCH (2014)
Indications for postoperative radiotherapy in laryngeal carcinoma: A panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study
Gino Marioni et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
Joseph M. Curry et al.
SEMINARS IN ONCOLOGY (2014)
Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma
Marco Lionello et al.
ACTA OTO-LARYNGOLOGICA (2012)
Essentials for an updated epidemiology of laryngeal carcinoma
Gino Marioni
CANCER TREATMENT REVIEWS (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival
Gino Marioni et al.
HISTOPATHOLOGY (2010)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma
G. Marioni et al.
EJSO (2006)
The role of supracricoid laryngectomy for glottic carcinoma recurrence after radiotherapy failure: a critical review
Gino Marioni et al.
ACTA OTO-LARYNGOLOGICA (2006)
分享论文
